General Electric Company (GE) is selling its biopharma business to Danaher for $21.4 billion, the company announced Feb. 25. With a definitive agreement signed between the two parties, GE’s previous plan to spin off its healthcare sector with its own initial public offering is likely put on hold, GE Chairman and CEO Larry Culp told CNBC.

Drug middlemen gobbled up $123.5 million in hidden costs in Kentucky’s Medicaid program, according to a new report from the Kentucky’s Cabinet for Health and Family Services.

A former employee of UnitedHealth Group’s Optum business is allowed to work for the new healthcare joint venture between Amazon, Berkshire Hathaway and JPMorgan Chase, a U.S. District Court judge ruled.

The use of low-value procedures is harming patients, consuming hospital resources and delaying care for patients for whom the services would be appropriate, according to a new assessment of seven low-value procedures published in JAMA Internal Medicine.

A report from The Wall Street Journal has led some popular health and wellness apps to cease data sharing with social network company Facebook after the practice was revealed.

Burnout among physicians improved slightly over the last few years, but not all specialties have seen much of a difference, according to data published in Mayo Clinic Proceedings.

A proposed merger between two major health insurance providers ended in a messy breakup after antitrust issues prohibited the roughly $50 billion transaction in 2017. Now, the two companies, Anthem and Cigna, are still disputing which company will foot the costs of the failed deal, Bloomberg Quint reported.

A study published in JAMA Open Network found Asian physicians received lower likelihood to recommend (LTR) scores, compared to non-Hispanic white physicians. With this in mind, health organizations using patient satisfaction scores for physician compensation and promotion should adjust for patient race and ethnicity.

CivicaRx, the not-for-profit entity created last year by a group of health systems and hospitals, is planning to achieve its goals of lowering drug prices and addressing shortages in hospitals by working directly with pharmaceutical companies and buying drugs, Bloomberg reported.

Some companies in particular are rising above the fray with their innovative solutions, according to Fast Company, which ranked the most innovative companies for 2019 across industries and overall.


Opioid-related deaths, particularly those associated with synthetic opioids, have impacted the eastern states, according to new research published in JAMA Network Open. Washington D.C. had the highest increase in death rates across the U.S.—more than tripling every year since 2013.

Getting to and waiting for a doctor’s appointment will likely take longer than getting a car repair, according to a recent analysis of travel and wait times among professional services by Altarum. All that waiting and traveling adds up to a significant burden in the U.S.–– an average of $89 billion annually in economic costs from 2006 to 2017.